Total Payments
$5,018
2024 Payments
$214.09
Companies
29
Transactions
279
Medicare Patients
2,802
Medicare Billing
$566,117
Payment Breakdown by Category
Food & Beverage$4,854 (96.7%)
Education$164.25 (3.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,854 | 273 | 96.7% |
| Education | $164.25 | 6 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $928.34 | 41 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $484.80 | 32 | $0 (2024) |
| Grifols USA, LLC | $476.91 | 25 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $404.02 | 22 | $0 (2024) |
| Mylan Specialty L.P. | $341.34 | 19 | $0 (2024) |
| GlaxoSmithKline, LLC. | $338.61 | 28 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $330.87 | 24 | $0 (2020) |
| Philips Electronics North America Corporation | $213.08 | 11 | $0 (2023) |
| Shire North American Group Inc | $183.44 | 11 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $178.73 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $214.09 | 12 | Mylan Specialty L.P. ($77.99) |
| 2023 | $339.01 | 17 | Grifols USA, LLC ($78.18) |
| 2022 | $535.63 | 27 | Philips Electronics North America Corporation ($89.72) |
| 2021 | $822.17 | 38 | Takeda Pharmaceuticals U.S.A., Inc. ($463.06) |
| 2020 | $664.73 | 37 | Takeda Pharmaceuticals U.S.A., Inc. ($292.92) |
| 2019 | $794.32 | 43 | Regeneron Healthcare Solutions, Inc. ($139.67) |
| 2018 | $1,109 | 69 | AstraZeneca Pharmaceuticals LP ($177.15) |
| 2017 | $539.86 | 36 | GlaxoSmithKline, LLC. ($78.26) |
All Payment Transactions
279 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: IMMUNOLOGY | ||||||
| 09/09/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: IMMUNOLOGY | ||||||
| 05/06/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/26/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $16.98 | General |
| Category: Narcoplepsy | ||||||
| 04/15/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Pulmonology | ||||||
| 02/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: RESPIRATORY | ||||||
| 01/29/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $18.80 | General |
| Category: Narcoplepsy | ||||||
| 01/22/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Pulmonology | ||||||
| 01/16/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/13/2023 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Pulmonology | ||||||
| 10/16/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Neurology | ||||||
| 10/04/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/02/2023 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $16.69 | General |
| Category: Medical Device | ||||||
| 09/11/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Respiratory | ||||||
| 08/30/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $20.48 | General |
| 08/29/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/22/2023 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Pulmonology | ||||||
| 07/17/2023 | Philips Electronics North America Corporation | (7999) SRC Und (Device) | Food and Beverage | Cash or cash equivalent | $13.98 | General |
| Category: Medical Device | ||||||
| 07/11/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: IMMUNOLOGY | ||||||
| 07/03/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: RESPIRATORY | ||||||
| 05/08/2023 | Philips Electronics North America Corporation | (7999) SRC Und (Device) | Food and Beverage | Cash or cash equivalent | $20.43 | General |
| Category: Medical Device | ||||||
| 05/03/2023 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Pulmonology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 634 | 1,032 | $256,951 | $115,332 |
| 2022 | 14 | 613 | 1,091 | $258,948 | $117,819 |
| 2021 | 14 | 869 | 1,631 | $445,887 | $160,990 |
| 2020 | 7 | 686 | 1,757 | $326,520 | $171,976 |
Total Patients
2,802
Total Services
5,511
Medicare Billing
$566,117
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 160 | 388 | $59,694 | $35,494 | 59.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 114 | 174 | $105,218 | $29,038 | 27.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 98 | 151 | $21,895 | $13,721 | 62.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 56 | 88 | $16,720 | $11,112 | 66.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 62 | 71 | $19,606 | $9,527 | 48.6% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 16 | 16 | $14,305 | $7,256 | 50.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 34 | 34 | $6,252 | $3,443 | 55.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 25 | 41 | $4,631 | $2,507 | 54.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $3,575 | $2,177 | 60.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 12 | $1,200 | $709.29 | 59.1% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 15 | 15 | $375.00 | $136.80 | 36.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 14 | 14 | $1,680 | $109.48 | 6.5% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 15 | 15 | $1,800 | $101.85 | 5.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 121 | 350 | $51,794 | $27,972 | 54.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 75 | 134 | $77,987 | $22,932 | 29.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 69 | 131 | $24,890 | $18,115 | 72.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 107 | 189 | $27,405 | $17,117 | 62.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 75 | 89 | $39,992 | $13,261 | 33.2% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 14 | 14 | $11,200 | $6,623 | 59.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 43 | 72 | $7,259 | $4,058 | 55.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $3,850 | $2,226 | 57.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 19 | 22 | $6,150 | $2,103 | 34.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $2,420 | $1,227 | 50.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 16 | 16 | $1,920 | $699.64 | 36.4% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 16 | 16 | $1,440 | $526.57 | 36.6% |
About Dr. Syed Ali, MD
Dr. Syed Ali, MD is a Sleep Medicine healthcare provider based in Port Huron, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1588664775.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Syed Ali, MD has received a total of $5,018 in payments from pharmaceutical and medical device companies, with $214.09 received in 2024. These payments were reported across 279 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,854).
As a Medicare-enrolled provider, Ali has provided services to 2,802 Medicare beneficiaries, totaling 5,511 services with total Medicare billing of $566,117. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Sleep Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Port Huron, MI
- Active Since 07/28/2005
- Last Updated 07/15/2021
- Taxonomy Code 207RS0012X
- Entity Type Individual
- NPI Number 1588664775
Products in Payments
- GLASSIA (Biological) $1,112
- Prolastin-C Liquid (Biological) $370.82
- NUCALA (Biological) $215.02
- FASENRA (Drug) $191.89
- Yupelri (Drug) $164.90
- DUPIXENT (Biological) $153.22
- LONHALA MAGNAIR (Drug) $150.62
- (7999) SRC Und (Device) $124.13
- YUPELRI (Drug) $123.82
- Wakix (Drug) $119.64
- SYMBICORT (Drug) $118.80
- STIOLTO RESPIMAT (Drug) $116.38
- Prolastin-C (Biological) $106.09
- OFEV (Drug) $102.57
- CHARTIS CATHETER (Device) $100.55
- SPIRIVA RESPIMAT (Drug) $94.64
- Zemaira (Biological) $91.45
- CHANTIX (Drug) $64.07
- UTIBRON (Drug) $63.34
- Xyrem (Drug) $62.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.